MyMD Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Polices)
Notes Tables
Notes Details

Major Customers

Major Customers	3 Months Ended
Mar. 31, 2016
Major Customers [Abstract]
Major Customers	Note 14 Major Customers For the three months ended March 31, 2016, two customers each generated more than 10% of the Companys product revenue. In aggregate, sales to these customers accounted for 74% of the Companys product revenue. As of March 31, 2016, the amount due from these two customers was $500,742. This concentration makes the Company vulnerable to a near-term severe impact should the relationships be terminated. For the three months ended March 31, 2015, two customers each generated more than 10% of the Companys product revenue. Sales to these customers accounted for 66% of the Companys product revenue.

Major Customers

3 Months Ended

Mar. 31, 2016

Major Customers [Abstract]

Major Customers

Note 14 Major Customers

For the three months ended March 31, 2016, two customers each generated more than 10% of the Companys product revenue. In aggregate, sales to these customers accounted for 74% of the Companys product revenue. As of March 31, 2016, the amount due from these two customers was $500,742. This concentration makes the Company vulnerable to a near-term severe impact should the relationships be terminated.

For the three months ended March 31, 2015, two customers each generated more than 10% of the Companys product revenue. Sales to these customers accounted for 66% of the Companys product revenue.